The North America market for Blood Collection is expected to grow between 2023 and 2032, due to factors like the rising prevalence of chronic diseases, development of innovative blood collection devices, public health initiatives.
The North America Blood Collection Market was valued at USD 2,000.6 Million in 2022 and is projected to reach USD 3,717.08 Million by 2032, registering a CAGR of 6.5% for the forecast period 2023-2032.
North America Blood Collection Market: Overview
Blood collection is an important activity in healthcare that is used for a variety of diagnostic, therapeutic, and research objectives. It entails drawing blood from a patient's vein, usually in the arm, with sterile and disposable equipment such as needles, syringes, or evacuated tubes. The primary goal is to get a sample that accurately represents the individual's blood composition, allowing for the examination of several parameters such as complete blood count, blood chemistry, and infectious disease indicators. Blood collection is typically performed by phlebotomists, nurses, or other trained healthcare professionals, who ensure accurate patient identification, specimen integrity, and adherence to established standards. Blood samples can then be taken and transferred to a laboratory for analysis, assisting in the diagnosis and monitoring of medical disorders. The procedure is essential in modern medicine, since it aids in illness detection, treatment planning, and overall patient care.
North America Blood Collection Market – Covid-19 Analysis
The COVID-19 epidemic has had a substantial influence on the blood collection market in North America. The crisis caused disruptions in normal healthcare services, such as blood collection. With lockdowns, social distancing measures, and a greater emphasis on handling COVID-19 cases, there was a decrease in elective medical operations and blood donation events, potentially leading to a blood supply deficit. The epidemic also complicated the supply chain for blood collection equipment and supplies. Concerns regarding viral transmission also influenced people's willingness to donate blood. While efforts were made to modify processes to assure donor and worker safety, the blood collecting environment faced unprecedented obstacles. The North American healthcare industry has been attempting to solve these concerns, emphasizing the significance of maintaining a strong and resilient blood collection system to satisfy both routine healthcare needs and anticipated surges in demand during health crises.
North America Blood Collection Market – Drivers
- Rising prevalence of chronic diseases: The increased frequency of chronic diseases has become a major driver of the North American Blood Collection Market's expansion. Chronic disorders such as cardiovascular disease, diabetes, and various types of cancer frequently necessitate regular monitoring and diagnostic testing, including blood-based assessments. As the prevalence of these diseases continues to rise in the region, so does the demand for blood collection services and products. Routine blood tests are critical for disease identification, treatment efficacy monitoring, and overall patient health assessment. As a result of this tendency, there is a greater demand for blood collection processes in hospitals, clinics, and diagnostic laboratories. Furthermore, North America's aging population adds to a higher prevalence of chronic diseases, fueling demand for blood collection services to enable effective disease management and healthcare interventions.
- Development of innovative blood collection devices: The development of novel blood collection devices is a major driving force in the growth of the North American Blood Collection Market. Technological and material advancements have resulted in the development of more efficient, less intrusive, and user-friendly blood collecting instruments. These advancements aim to improve the entire patient experience, improve sample collection accuracy, and promote the safety of healthcare staff participating in the process. The advent of vacuum blood collection equipment, safety-engineered needles, and specialized lancets, for example, has expedited the blood collection process, decreasing contamination risk and ensuring correct sample amounts. Furthermore, incorporating smart technology such as barcode systems and radio-frequency identification (RFID) improves traceability and aids in the prevention of errors in patient identification and sample tracking. These developments not only increase blood collection efficiency, but they also drive market growth by attracting healthcare providers wanting to implement cutting-edge technologies for better patient care and laboratory operations.
- Public health initiatives: By encouraging awareness, education, and active involvement in blood donation programs, public health efforts play an important role in driving the North America Blood Collection Market. Various governmental and non-governmental groups, as well as healthcare institutions, participate in voluntary blood donation campaigns and programs. These initiatives are aimed at teaching the public on the necessity of frequent blood donation, highlighting its role in saving lives, supporting medical treatments, and responding to crises. Public health programs also work to address myths and misconceptions about blood donation in order to develop a good attitude about the process. These efforts' improved awareness and engagement contribute to a consistent and sustainable blood supply, enhancing the healthcare system's ability to meet demand for blood products and services. As a result of the joint efforts of public health campaigns aimed at creating a culture of voluntary and frequent blood donation for the sake of community health, the North America Blood Collection Market benefits.
- Needles and Syringes: Needles and syringes are essential parts of the blood collection procedure. Needles are used for venipuncture, which involves inserting a needle into a vein to draw blood, whereas syringes allow for the controlled collection of blood samples. Innovations in needle design aim to reduce patient discomfort while also enhancing healthcare worker safety, frequently including elements such as safety-engineered mechanisms.
- Blood Collection Tubes: Blood collection tubes are necessary vessels for holding blood samples after they have been collected. There are different sorts of tubes, each designed for a specific test, such as chemistry, hematology, or coagulation assays. Different colored tips indicate the type of additive included within the tube, assuring sample integrity and reliable test results. Tube technology advancements aim to increase sample stability, speed processing, and improve interoperability with automated laboratory equipment.
- Blood Lancets: Lancets are small, disposable devices used for capillary blood collection. They are commonly used for glucose monitoring or when only a small amount of blood is required. These devices have become more user-friendly, with features including changeable depth settings and ergonomic designs that improve patient comfort and safety during self-monitoring operations.
- Blood Bags: Blood bags are specialized containers that are used to collect, store, and transport donated whole blood or its components such as red blood cells, plasma, and platelets. These bags include anticoagulants and preservatives to ensure the viability of blood components. Blood bag design innovations aim to improve storage conditions, increase shelf life, and ensure the safety of the blood supply.
- Blood Collection Systems/Monitor: Blood collection systems or monitors are extensive setups that may comprise automated blood collection, processing, and monitoring devices. For reliable sample tracking, these systems frequently incorporate technology such as barcoding and RFID. The focus is on increasing workflow efficiency, decreasing errors, and maintaining traceability throughout the blood collection and processing phases, all of which contribute to overall laboratory productivity and quality assurance. These advancements aim to improve patient safety and optimize productivity for healthcare personnel involved in blood collection.
- Diagnostics: Blood collection is critical in diagnostics for getting samples that provide vital insights into an individual's health. Blood is a rich source of data, allowing for the evaluation of numerous parameters such as complete blood count, blood chemistry, and the existence of biomarkers. Diagnostic applications include everything from normal health checks to the diagnosis and monitoring of various medical disorders such as infections, anemia, diabetes, and cardiovascular disease. Accurate diagnostic testing requires precise and dependable blood collection, which allows healthcare practitioners to make educated decisions about patient care and treatment strategies.
- Treatment: Blood collection is also important in therapeutic applications, particularly in the collecting of specific blood components for transfusion or therapeutic interventions. Whole blood or its constituents, such as red blood cells, plasma, and platelets, are collected and processed for distribution to patients in need. This is especially important during operations, trauma, and certain medical illnesses such as anemia or blood disorders. Blood taken for treatment is carefully processed and stored to ensure its safety and efficacy, ultimately contributing to life-saving treatments and medical procedures that rely on a consistent and enough blood supply.
By End User:
- Hospitals: Hospitals are important users of blood collection supplies, using them for a variety of medical operations, diagnostic tests, and therapeutic interventions. Blood collection is essential in hospitals for everyday patient care, emergency circumstances, operations, and a wide range of medical treatments. The necessity for precise and quick diagnostic information, as well as the need for blood transfusions during operations and medical treatments, impact the demand for blood collection products in hospitals.
- Diagnostic Centers: Diagnostic facilities specialize in offering specialized testing services, and blood collection is an important part of their business. These facilities use blood samples to perform a wide range of diagnostic procedures, assisting in illness detection and monitoring. Because the efficiency and precision of blood collection have a direct impact on the dependability of diagnostic results, high-quality blood collection tools are critical for diagnostic centers to give accurate and timely information to healthcare practitioners and patients.
- Blood Banks: Blood banks are specialized facilities that collect, store, and distribute blood and its components. These organizations are crucial in assuring a consistent and safe blood supply for medical treatments and emergencies. Blood collection items are used in blood banks to collect whole blood donations and separate them into components such as red blood cells, plasma, and platelets. The quality and safety of blood collection products are critical in blood banks to ensure the integrity of the blood supply and compatibility with a wide range of patient needs.
- Other End Users: Beyond hospitals, diagnostic institutes, and blood banks, the category of "Other End Users" includes a wide range of healthcare settings. Clinics, research laboratories, ambulatory care centers, and other healthcare institutions that use blood collection items for specific medical procedures, research, or point-of-care testing may fall into this category. The diversified nature of these end users reflects the wide range of uses for blood collection devices in the healthcare business, underlining the need for bespoke solutions to address the specific needs of various healthcare settings.
North America dominated the Blood collection market over the forecast period due to several variables, including an increase in injuries and a rise in the prevalence of chronic conditions necessitating routine blood sample collection. The surge in diabetes prevalence and the resulting increase in healthcare spending are anticipated to further fuel market growth. For instance, according to the International Diabetes Federation's 10th edition Diabetes Atlas, 32.2 million Americans had diabetes in 2021, with a projected rise to 36.3 million by 2045. Additionally, it is projected that the region's major market players would execute several initiatives that will support market expansion. For instance, in December 2021, Tru-Immune, a finger prick, self-collection kit for its COVID-19 neutralizing antibody test, was introduced by Ethos Laboratories, a leader in diagnostic testing services authorized and certified by the College of American Pathologists. Furthermore, BD (Becton, Dickinson, and Company) introduced UltraSafe Plus 2.25 mL in February 2022, a brand-new needle-guard product that improves the delivery of pharmaceuticals and other biologic solutions. In addition, the rise in surgical procedures—which often demand blood collection—is anticipated to fuel market expansion.
|Market Size in 2022
|USD 2,000.6 Million
|Market Forecast in 2032
|USD 3,717.08 Million
|Compound Annual Growth Rate (CAGR)
|Revenue (USD Million) and Volume (Kilo Tons)
|By Product, By Application, By End User
|By End User
|2018 - 2022
|2023 - 2032
List of Prominent Players:
- Terumo Corporation
- Nipro Medical
- Cardinal Health
- Greiner AG
- SARSTEDT AG
- QIAGEN N.V.
- AdvaCare pharma
- Improve Medical
- FL Medical s.r.l.
- Needles and Syringes
- Blood Collection Tubes
- Blood Lancets
- Blood Bags
- Blood Collection Systems/Monitor
- Diagnostic Centers
- Blood Banks
- Other End Users